ACE and Myocardial fibrosis: Of note, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) were shown to reduce the development of myocardial fibrosis and hypertrophy, as well as LV adverse remodeling, hence reducing the onset of HF [35].